APA aipamena

Katugampola, S. D., & Davenport, A. P. (2001). Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan.

Chicago Style aipamena

Katugampola, Sidath D., and Anthony P. Davenport. Thromboxane Receptor Density Is Increased in Human Cardiovascular Disease With Evidence for Inhibition At Therapeutic Concentrations By the AT(1) Receptor Antagonist Losartan. 2001.

MLA aipamena

Katugampola, Sidath D., and Anthony P. Davenport. Thromboxane Receptor Density Is Increased in Human Cardiovascular Disease With Evidence for Inhibition At Therapeutic Concentrations By the AT(1) Receptor Antagonist Losartan. 2001.